Additional definitive proxy soliciting materials and Rule 14(a)(12)[...]
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating[...]
04/02/2023 | Press release | Distributed by Public on 04/02/2023 00:50
Please select the service you want to use:
Smartlinks | My Size Inc. | News | Finance | Security Markets | Security Markets | Company News | Business Announcement | Investment Funds | Information Technology | Software | Public Companies | Software Companies | Frankfurt Stock Exchange | Tel Aviv Stock Exchange (TASE) | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact